Web Analytics

3 Latest Announced Rounds

  • $8,500,000
    Series A

    2 Investors

    Software Development
    Apr 17th, 2026
  • $17,000,000
    Series A

    2 Investors

    Hospital & Health Care
    Apr 17th, 2026
  • $2,750,000
    Pre-Seed

    2 Investors

    Technology, Information and Internet
    Apr 17th, 2026
$1,935.65M Raised in 48 Funding Rounds in the past 7 Days - View All

Funding Round Profile

IMU Biosciences

start up
United Kingdom - London
  • 25/01/2024
  • Series A
  • $14,639,787

Mapping the immune system in unprecedented detail and scale. IMU’s discovery platform is building a new understanding of the immune system across health and disease, through next generation high resolution, systems-level immune profiling with AI & ML analytics.


Related People

Adam LaingCo Founder

Adam Laing United Kingdom - London, England

N/A